Suministro de medicamentos con principios activos Ustekinumab y Adalimumab 80 mg
TED · 304490-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded€2,901,898 · 2,901,898.04 EUR
WinnerFRESENIUS KABI ESPAÑA, S.A. | BIOCON BIOLOGICS SPAIN, S.L. | JANSSEN CILAG, S.A. | SANDOZ FARMACEUTICA S.A.
Who already wins at this buyer
Firms with recorded awards from Servicio Murciano de Salud - Junta de Compras in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| TAKEDA FARMACÉUTICA ESPAÑA, S.A. | PFIZER, S.L. | SWEDISH ORPHAN BIOVITRUM, S.L. (SOBI) | BAYER HISPANIA, S.L. | NOVO NORDISK PHARMA, S.A. | 1 | €9,441,858 | 2026-07-20 |
| PRIM, S.A | Medline International Iberia SLU | LABORATORIOS HARTMANN SA | GARRIC MEDICA, S.L. | BARNA IMPORT MEDICA S.A. | SUMINISTROS HOSPITALARIOS S.A. | LUHEPA INTERNACIONAL,S.L. | PALEX MEDICAL S.A. | Mölnlycke Health Care, S.L | 1 | €5,681,474 | 2026-08-26 |
| NOVARTIS FARMACÉUTICA, S.A | TEVA PHARMA, S.L.U. | ORGANON SALUD, S.L. | 1 | €3,508,148 | 2026-09-17 |
| SANOFI AVENTIS, S.A. | 1 | €2,800,000 | 2026-07-13 |
| AMGEN, S.A. | ROCHE FARMA, S.A. | PFIZER, S.L. | 1 | €2,509,350 | 2026-07-27 |
Full buyer profile: what Servicio Murciano de Salud - Junta de Compras buys and who wins it →
CPV codes
33652300 Medical equipment & pharmaceuticalsDescription
Suministro de medicamentos con principios activos Ustekinumab y Adalimumab 80 mg para los Centros dependientes del Servicio Murciano de Salud
Similar tenders
Closest by meaning — across languages, via embeddings.